Hero MotoCorp Ltd. makes a corporate announcement

The Rs 1,000 crore preferential infusion was expected to raise Hero MotoCorp’s holding in Ather Energy to 30.68% on a fully diluted basis, from 29.48%, upon conversion of the warrants. The warrants were allotted at Rs 1,260 each, with 25% paid upfront and the balance payable on exercise. ^{[1] [2]}

This does not change Ather’s classification as an associate in Hero MotoCorp’s consolidated financial statements. The transaction was explicitly described as an investment in Hero MotoCorp’s associate company, and Ather continued to be included among the associates in the consolidated reporting framework. ^{[3] [4]}

Important distinction: the subsequent, separate purchase of Ather shares for approximately Rs 1,758 crore raised Hero MotoCorp’s holding further to approximately 32.8% on a fully diluted basis. ^[5] That later block purchase also did not indicate a change from associate status.

The Rs 1,000 crore figure was an approved investment limit; the actual warrant subscription was approximately Rs 960 crore, with only 25%—about Rs 240 crore—paid upfront. It should be treated as an investment asset, not an operating expense. The corresponding cash reduction is therefore matched by an increase in an investment-related asset, subject to the final Ind AS classification and subsequent valuation or impairment treatment.

Accounting treatment

• Hero MotoCorp subscribed to 7,619,047 convertible warrants in Ather Energy at Rs 1,260 per warrant, for an aggregate commitment of Rs 959.999992 crore. Each warrant is convertible into one Ather equity share. ^[2]
• The initial payment was Rs 239.9999805 crore, representing 25% of the issue price. The remaining 75%, approximately Rs 720 crore, becomes payable only if Hero exercises the warrants. ^[2]
• Since Ather is described as an associate company, the transaction is strategic in nature. However, the warrants are not yet equity shares; the precise standalone balance-sheet line item—whether presented as an investment in warrants, advance against investment, or another financial-asset category—is not identified in the cited disclosure. ^[2]
• The initial payment should therefore move value from cash into an investment-related asset. It is not, at inception, a charge to operating expenses or an immediate reduction in reported equity. Subsequent accounting will depend on the applicable Ind AS classification and any fair-value or impairment assessment.

Impact on standalone cash

The latest standalone balance-sheet cash figure available is Rs 531.59 crore for Q4 FY26, i.e. 31 March 2026. ^[6] The warrant payment was made later, on 25 August 2026, so it does not affect that already-reported balance sheet. ^[2]

Mechanically:

• Reported cash before the warrant payment: Rs 531.59 crore. ^[6]
• Upfront payment: approximately Rs 240 crore. ^[2]
• Illustrative cash after that payment: approximately Rs 291.59 crore, calculated as Rs 531.59 crore minus Rs 240 crore. This is not a reported balance-sheet figure and assumes no intervening cash flows.
• The remaining approximately Rs 720 crore is a future commitment, not a current cash outflow; it would affect cash only if Hero exercises the warrants.

Thus, the immediate economic effect is a potential Rs 240 crore reduction in cash and a corresponding investment asset increase, while the June 2026 or next reported standalone balance sheet—not the 31 March 2026 balance sheet—would capture the payment.

The Rs 1,000 crore Ather allocation cannot be shown to be larger or smaller than Vida’s cumulative capex for FY25-FY26, because Hero MotoCorp has not separately disclosed Vida-specific capex for those two years. The comparison is also between unlike capital uses: the Ather amount was an announced investment in another company, whereas Vida capex would be operating investment in Hero’s own EV business.

The closest reported proxy is not directly comparable: Hero said its FY25 EV-business investment was approximately Rs 630 crore, but this was described as an EV-business investment affecting EBITDA, not as Vida-specific capex ^[8]. Similarly, the Rs 208 crore EV-business investment in Q3 FY26 was an EBITDA investment for that quarter, not capex ^[9]. These figures cannot be summed to create a two-year Vida capex number.

Analytical implication: the Rs 1,000 crore Ather allocation represents a clearly identifiable external strategic investment, while Hero’s internal Vida spending is embedded across capacity, R&D, brand-building, charging infrastructure and other EV activities. Hero disclosed a broader Rs 1,500 crore FY27 capex commitment, but that covers company-wide growth investments—not Vida alone—and therefore should not be used as the comparator ^[10].